Many cancer patients, family members cite positives in experience

NewsGuard 100/100 Score

Almost two out of three cancer patients and their families believe that "something good has come out of their experience," according to a recent telephone survey jointly conducted by USA Today, the Kaiser Family Foundation and the Harvard School of Public Health (Szabo, USA Today, 11/21).

The survey included a nationally representative sample of 930 adults ages 18 and older who said that they or family members in their households were diagnosed with or treated for cancer in the past five years (Kaiser Daily Health Policy Report, 11/20).

About half of respondents said that cancer changed their outlook on life, in most cases positively, the survey found. According to the survey, 69% of respondents ages 18 to 49 said that cancer changed their outlook on life, compared with 36% of those ages 65 and older (USA Today, 11/21).

Full results from the survey, which provides an in-depth examination of how families cope with cancer and highlights problems of health insurance and health care costs through the lens of those who have experienced this major illness, are available online.


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Insilico Medicine's AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy